Please ensure Javascript is enabled for purposes of website accessibility

1 Big Problem With Canadian Marijuana Stocks

By Eric Volkman - Jan 19, 2021 at 10:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If only things would change south of their border...

At first glance, Canada looks like a marijuana industry paradise given that the drug is fully legal throughout the country. So why do homegrown companies like Cronos (CRON 0.33%) continue to struggle there?

In this video clip from Motley Fool Live, longtime Motley Fool contributor delves into one major reason for this in an interview with Cannabis and Healthcare bureau chief Corinne Cardina Jurney. The video was recorded on Dec. 22.



Corinne Cardina: How are Canadian companies like Cronos at a disadvantage in the U.S.?

Eric Volkman: Well, the big disadvantage is that they can't sell product here.

Again, marijuana is unambiguously illegal at the federal level, no matter what states do. Again, America, we have federal, states, they don't talk to each other -- whatever! They'll figure it out... maybe... eventually.

Canadian growers, producers, retailers are limited to Canada. The problem with Canada is, first of all, there's a lot of competition in every corner of the market, in every segment, from growers to retailers, and every segment has a lot of players. There's not an awful lot of elbow room, so it's like is claustrophobia. They're contained in this market that has its limits.

On top of that, the government, Health Canada specifically, over the past year they have improved, but the pace of licensing is still really, really slow. I think in mid-year [2020], I don't know the exact number -- somebody hopefully will correct me -- but in mid-year, in the province of Ontario, which is at the same time the capital province, and by far the most populous province in the country, they had a grand total of 24 dispensaries for the entire province.

And it's not like the country suddenly woke up and legalized weed, they first started doing this, in the recreational sphere, now more than two years ago. There's no excuse for two years after initial legalization, you still only have a handful of dispensaries, and it's a big province, it's a big country. It's 24 dispensaries.

If you live in a fairly obscure town, it's possible that you have to drive a couple of hours away to buy licensed weed, so why would you bother?

That leads to a second problem which is in Canada the black market is still thriving. Companies have done well, combating this to an extent, by introducing budget product lines. The problem with those is that of course because they're budget lines, their lower margins and that doesn't help their profitability -- or lack thereof.

So yeah, Canadian companies are a bit contained and bottlenecked in their country.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cronos Group Stock Quote
Cronos Group
$3.04 (0.33%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.